Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Most maternity units in Britain now offer serum screening for antenatal
detection of Down's syndrome. The evidence for serum screening came
from uncontrolled demonstration projects in which it was assumed, but
not shown, that the previous method of screening, by maternal age,
would identify only 20-30% of affected pregnancies. Howe et al
(p 606) describe the antenatal detection rate of Down's syndrome in a
district where screening is by maternal age and routine mid-pregnancy
ultrasound scanning. The overall detection rate was 68%, considerably
more than previously assumed. As a result, the benefits of serum
screening are much less than supposed. The authors emphasise the
importance of subjecting any new screening methods to properly
controlled trials.